propionyl-l-carnitine and l-carnitine HCl 030-000-375 Propionyl-L-carnitine Hydrochloride

Zhang L, Jing D, Jiang N, Rojalin T, Baehr CM, Zhang D, et al

OS, Observational Study

In fact, throughout the progression of the disease in oncological dogs and cats, the tendency is to observe these clinical manifestations (4)

Neurodegenerative disease potential Alzheimer's disease: May slow cognitive decline Protects cholinergic neurons (memory-critical) Reduces beta-amyloid toxicity (theoretical) Enhances neuroplasticity despite disease Not a cure but potential disease-modifying effect Parkinson's disease: Protects dopamine neurons in substantia nigra GDNF upregulation (critical for dopamine neurons) May slow motor symptom progression Supports brain resilience Used in Russian Parkinson's protocols Multiple sclerosis (MS): Neuroprotective for damaged neurons Supports myelin repair (theoretical) Reduces neuroinflammation May preserve cognitive function Part of comprehensive MS management Important caveats: Not a substitute: Continue conventional medical treatment Work with neurologist Pinealon as adjunct not replacement Part of comprehensive brain health strategy Learn about peptide therapy clinics and peptide safety

We only use certified ingredients

By eliminating the ACTH-evasive strategy of ACTH mimicry presented by these pathogens, it favors a more efficient immune response (42)